AI-generated summary
The authors report a double-blind randomized trial of blue-enriched light therapy versus conventional light in 60 institutionalized older adults with dementia over 10 weeks. They found improvements in objective and self-reported sleep measures and in overall behavioral and psychological symptoms, with some effects lasting up to 6 months. The abstract describes the approach as feasible and low-cost.
- Participants
- 60
- Who or what was studied
- Institutionalized older adults with dementia
- Limits stated in the abstract
- The abstract does not state explicit limitations of the trial.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on karger.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Dementia, Randomized controlled trial, Phototherapy, Light-emitting diode, Primary outcome. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.